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There is increasing evidence that parathyroid hor-
mone (PTH) and PTH-related peptides (PTHrP) are 
involved in normal skin cell growth; therefore, we 
investigated whether the PTH/PTHrP receptor was 
expressed in cultured human keratinocytes and der-
mal fibroblasts. Northern analyses of poly (A)+ RNA 
isolated from cultured fibroblasts revealed two PTH/ 
PTHrP receptor transcripts with one major band at 
2.5 kb and one minor band at 2.3 kb. These tran-
scripts were consistent with those found in human 
osteosarcoma cells, which are known to express PTH/ 
PTHrP-R mRNAs. In contrast, after repeated North-
ern analyses no PTH/PTHrP receptor transcripts 
were found in poly (A)+ RNA isolated from cultured 
keratinocytes. Reverse-transcriptase/nested poly-
merase chain reaction analyses of total RNA isolated 
P ara. th.yroid .hormo. ne-r.·elated. peptide's (PTHrP) bioac-tivity was initially identified in tumors associated with humoral hypercalcemia of malignancy [1 ,2]. T he 141 amino acid PT HrP shares 70'% homology with PTH in its first 13 amino acids but diverges completely in its 
primary structure thereafter. Studies using synthetic PT HrP N-
termina l fi·agm ents have demonstrated tha t fragments that bound to 
the PTH receptor have caused biologic responses similar to PTH in 
cultured bone and kidney cells [3). Several groups have postulated 
that a single receptor species, at least in bone and kidney cells. m ay 
m ediate many physiologic fun ctions of both PTH and PTHrP 
[4-6). A human PTH/ PTHrP receptor eDNA encoding a 593 
amino acid protein has been cloned [7] . Using a eD NA probe for 
thls PTH/PTHrP receptor, Urena e/ a/ [8) demonstrated PT H / 
PTHrP receptor transcripts in many nonclassical PTH target organs 
and tissues, including the skin. T wo equally abundant PTH/ PTHrP 
receptor transcripts were present in poly (A) + R.N A isolated fro m 
whole rat skin ; a 2.3- 2 .5-kb transcript, identical to that fo und in 
bone and kidney and a small er 2.0 - 2.2-kb transcript. T he data 
support early e li.']Jet;mentation that suggested PT H receptors w ere 
present in skin fibroblasts [9). 
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from cultured keratinocytes and fibroblasts con-
firmed the Northern analyses data that the PTH/ 
PTHrP receptor was expressed in cultured fibroblasts 
but not in cultured keratinocytes. When cultured 
fibroblasts and keratinocytes were exposed to 10- 7 M 
PTH (1-34) there was a twofold increase in cAMP 
levels in the fibroblasts and no demonstrable increase 
was noted in keratinocytcs. These results suggest that 
skin fibroblasts possess the classical PTH/PTHrP re-
ceptor and are target cells for PTH and PTHrP 
whereas keratinocytes do not have the receptor and 
are unresponsive to its N-terminal agonist in the 
stimulation of cAMP formation. Ke]l 1vords: cAMPI 
nested PCR/3T3 fiiJroblasts. ] ln11est D emwtol 105:133-
137, 1995 
A variety of nonnal tissues syn thesize and secrete PTHrP [3] . In 
fact, th e presence of PTHrP bioactivity in nonmalignan t cells was 
first dem onstrated in conditio ned medium harvested from conflu-
ent human keratinocytc cultures [1 0). However, the physiologic 
ro le and the functional pathway of this peptide in n orm al skin is still 
unclear , although some have suggested that PTHrP m ay fi.tn ction as 
an autocrin e or paracrine factor [3, 11 J. In 11itro and i11 11i11o studies in 
our labo ratory have demonstra ted that PTH (1-34) and PTHrP 
(1 -34) are po ten t inhibitors of epidermal cell proliferation and PT.H 
(7-34) , an antagonjst of the PTH/ PTHrP receptor, can block the 
antiproliferative effect of PTH (1 -34) and stimulate epiderma l 
proliferation in cul tured keratinocytes [12,13). Additionally, Kaiser 
et a/ [14) , after expressin g an antisense PTHrP sequence in an 
established human kera tinocyte cell line, demonstrated enhanced 
keratinocyte ce ll gmwth. 
ln considering these respon ses of keratinocytes to PTH and 
PTHrP, we wondered if the PTH/ PTHrP receptor. p resum ably at 
least one m ediato r for th e bio logic expressio n of both the PTH and 
PT.HrP hormones, w as presen t in cultured human keratinocytes and 
fibroblasts. Because PTH stimul ates the fom1ation of cyclic aden-
osine monophosphate (cAMP) in ta rget tissues l,l110wn to express 
the receptor, we m easured intra cellular cAM P levels in keratino-
cytes and fibroblasts after treatm ent with PTH (1-34). To deter-
mine mR.NA expression , w e also performed N or them ana lyses on 
poly (A) + from cultured keratinocytes and fibroblasts usin g a 
eDNA that codes for a common human PTH/ PTHrP receptor [15) . 
Additionally, w e perform ed reverse transcriptase (RT) and nes ted 
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polymerase chain reaction (PCR) analyses on total RNA isolated 
from human keratinocytes and both human and mouse fibroblasts. 
EXPERIMENTAL PROCEDURES 
Cell Culture Keratinocytes were grown in culture using a 
modification of Rheinwald and Green [1.6]. Keratinocytes were 
obtained from neonatal foreskins and plated on a lethally irradiated 
3T3 feeder layer in a serum-free MCDB 153 basal medium con-
taining 0.15 mM calcium and supplemented with growth factors, 
including bovine pituitary extract, 3 ~J.g/ml; epidermal growth 
factor, 25 ng/ml; insulin, 5 ~J.g/ml; hydrocortisone, 200 ng/ml; 
cholera toxin , 0.1 !J.glml, and prostaglandin E 1, 50 ng/m] [17]. 
Cells were fed and maintained in the same medium without cholera 
toxin and hydrocortisone three times per week. Second-passage 
keratinocytes grown on 1 00-mm or 35-mm dishes were used for 
Northern ana.lyses or cAMP determinations, respectively. To avoid 
the potentia l contamination of 3T3, some primary cultured kerati-
nocytes were grown without a 3T3 feeder layer for reverse-
transcriptase/polymerase chain reaction (R T /PCR) analyses. Nor-
mal fibroblasts were grown from buman foreskins in Dulbecco's 
modified Eagle's medium supplemented with 5% fetal bovine 
serum as previously described [1 8]. For RT /PCR experiments, 
cells were harvested from single 1 00-mm dishes. Total RNA from 
human osteoblast- like osteosarcoma cells (SaOS-2) for both North-
em and R T /PCR analyses was extracted and purified as described 
[15]. 
cAMP Determination For cAMP experiments, keratinocytes 
and fibroblasts were plated on 35-mm dishes. Growth factors were 
removed from the keratinocyte media and fetal bovine serum was 
removed from the fibroblast media 2 d before the e"-"(Jeriment. At 
the experiment's initiation, cells were preincubated for 30 min at 
37°C in 0.5 ml of fresh MCDB-153 or DMEM medium (Sigma, St. 
Louis, MO) for keratinocytes and fibroblasts , respectively, foLlowed 
by treating the cells with human parathyroid hormone (hPTH 1-34) 
(Bachem, Torrance, CA) at a final concentration of 10- 7 M or 
vehicle (phosphate-buffered· saline) only. Following incubation for 
10 min at 3 rc, the reaction was terminated by removing the 
medium and adding 0.5 ml of 0.1 N NaOH. The resulting cell 
suspension was neutralized with 1 N HCI and aliquots were 
quantitated using a commercial cAMP assay kit (Amersham, Ar-
Lington Heights, IL). Standard error of the mean was calcu la ted 
from triplicate determinations. 
Northern Analysis Total cellular RNA was prepared fi:om 
keratinocytes and fibroblasts using a modification of the guani-
dinium thiocyanate-cesium chloride technique [19]. Total RNA 
from mouse kidney was prepared in a similar marmer. Poly (A) + 
RNA was further isolated from keratinocyte and fibroblast by 
utilizing a PolyATtract mRNA Isolation System (Promega, Madi-
son , W I). Tota l RNA and poly (A) + samples were denatured and 
fractionated on a 1%/3 7% agarose/formaldehyde gel containing 
ethidium bromide. An RNA ladder (Gibco/BRL, Grand Island, 
NY) was also run to determine message size at the hybridization 
bands. The RNA was transferred via capil lary action to a nylon 
membrane, Hybond N (Amersham) and cross-linked to the mem-
brane 11ia an ultraviolet transilluminator (lBL) . Membranes were 
prehybridized at 42°C for 2 h in a solution containing 50% 
formamide, 100 !J.g/ml denatured nonhomologous DNA, 5 X SSC, 
0.5% sodium dodecyl sulfate, 10 X Denhardt's, fifty millimoles per 
liter of Na2P04 , and 10% dextran sulfate (Sigma). A eDNA 
(Genbank accession number, L04308) encoding a humru1 PTH/ 
PTHrP receptor [15] was labeled with [a32P] dCTP (Amersham) 
via the Prime-It II Random Primer Labeling Kit (Stratagene, La 
Jolla, CA) . A Sephadex G-50 column (Boehringer Mannheim 
Corp, Indianapolis, IN) was used to remove unincorporated free 
nucleotide. All blots were stripped and rehybridized with a human 
glycera ldehyde-3-phospbate dehydrogenase (GAPDH) oligonucle-
otide (Oncogene Science, Uniondale, NY), whose sequence was 
based on the eDNA . sequence cloned by Tso and colleagues [20]. 
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The oligonucleotide was 5 ' labeled with [y 2 P] ATP (Amersham). 
A Sephadex G-25 column (Boehringer Mannheim Corp) was used 
to remove unincorporated free nucleotide. Hybridizations took 
place overnight at 65 °C in a solution containing 1 M NaCI, 50 mM 
Tris-HCI (pH 7.5), 10% dextran sulfate, 1% sodium dodecyl 
sulfate, and 100 !J.g/ml denatured nonhomologous DNA (Sigma). 
Autoradiography of blots was carried out at -70°C using Hyper-
film (Amersham) and an intensifying screen (Dupont/NEN, Bos-
ton, MA) . 
RT/Nested PCR Analysis Total RNA aliqu ots (1 p,g) isolated 
from cu ltured lmman keratinocytes, grown either with or without 
a 3T3 feeder layer, human fibroblasts, human osteoblast-like 
osteosarcoma cells (SaOS-2), and immortalized mouse fibroblasts 
(3T3s) were added to separate reverse transcriptase (RT) reactions 
[21]. The buffer consisted of7.0 mM MgCI 2 , 50 mM KCI, 10 mM 
Tris-HCI (pH 8.3), deoxynucleotide triphosphates at 1 mM each, 1 
unit RNase inhibitor, 2.5 !J.M random hexamers, and 2.5 units of 
cloned Moloney Murine Leukemia Virus (M-ML V) Reverse Tran-
scriptase (Perkin-Elmer Cetus/ Applied Biosystems, Foster City, 
CA). The final volume for each reaction was 20 !J.l. The reaction 
mixtures were incubated at room temperature for 10 min, 42°C for 
45 min, 99°C for 5 min, and soc for 5 min. PCR amplifications 
were carried out in the Gene Amp PCR system 9600 (Perkin-Elmer 
Cetus). Amplifi cations were done in a final buffer volume of 100 !J.I 
consisting of 2 mM MgCI 2 , 50 mM KCI, 10 mM Tris-HCL (pH 
8 .3), and 2.5 units AmpliTaq DNA Polymerase (Perkin-Elmer 
Cetus). PCR for glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was performed using 1 0 !J.M of the forward primer 
5'-TCCCATCACCATCTTCCA-3 ' and 10 !J.M of the reverse 
primer 5 ' -GTCCACCACCCTGTTGCT -3'. PCR conditions were 
95°C for 2 min, followed by 35 cycles of95°C for 30 seconds, 60°C 
for 30 seconds, and 72°C for 30 seconds with a final extension at 
72°C for 5 min. Nested PCR [22] was used for the PTH/PTHrP-R. 
The outer forward primer 5'-GGGCACCAGGTGAAGTGGT-3 ' 
and the outer reverse primer 5 '-GGTTGCTCTGACAC-
CGACCC-3' were used for the first amplification. PCR conditions 
were 95°C for 2 min, followed by 30 cycles at 95°C for 30 seconds, 
55°C for 30 seconds, and 72°C for 30 seconds with a 3-second 
extension per cycle. Final extension was at 72°C for 5 min . For the 
second amplification , 5 !J.I of the first-round amplification mixture 
was added to the same mixtu.re as in the previous amplification but 
this time the inner primer concentrations were doubled to 20 !J.M 
rather than 10 !J.M. T he inner forward primer was 5'-CGGGAG-
GTAmGACCGCCTAG-3' and the inner reverse primer was 
5 '-CAGAA TCCAGT AGTAGTTGG-3'. PCR conditions were the 
same as for the first amplification except cycle duration was 25. 
Samples of 20 !J.I of PCR reaction products were analyzed by 
electrophoresis on a 2% agarose gel. Bands were visualized by 
eth.idium bromide staining. At some amplifications [ a 32P] dCTP 
(Amersham) was added to reaction mixtures and gels were dried 
and exposed to Hyperfilm (Amersham). The PCR amplification 
products for PTH/PTHrP-R were further analyzed for authenticity 
by restriction enzyme digestion with Fok I, Bsg I, and Drd I (New 
England Biolabs, Beverly, MA). 
RESULTS 
Stimulation of cAMP Production in Fibroblasts Treated 
with hPTH (1-34) The ability of a PTH N-terminal fi·agment to 
stimulate cAMP production was studied in cultured nom1al human 
keratinocytes and dermal fibroblasts. Treatment of fibroblasts with 
10 - 7 M of hPTH (1-34) caused a twofold increase in cAMP levels 
over the basal level (4.2 ::!:: 0.1 pmolldish versus 2.0 ::!:: 0.05 
pmolldish). The data were significantly different and p was < 0.005. 
In contrast, when keratinocytes were treated with 10- 7 M ofhPTH 
(1-34) no stimulation of cAMP formation was observed. Treated 
keratinocytes were 4.0 :::':: 0.2 pmol/dish and untreated keratino-
cytes were 3. 9 ::!:: 0.1 pmol/ dish. T here was no significant difference 
between these data points. Because hPTH (1-34) stimulated cAMP 
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formation in cultured fibroblasts but not in cultured keratinocytes , 
we exa mined whether cultured human fibroblasts and keratino-
cytes possessed the same PTH/ PTHrP receptors as those found in 
kidney and bone cells. 
Northern Blot Analysis Utilizing the recently cloned, full-
length human PTH/PTHrP receptor eD NA [15], Northem ana lysis 
was performed on poly (A) + RNA from cultured human keratino-
cytes and fibroblasts. In all hybridization experiments, approxi-
mately 10 }.Lg total RNA from mouse kidney cells and / or human 
osteoblast-like osteosarcoma cells (SaOS-2) were used as positive 
controls. Lane l of Fig lA contained the positive control SaOS-2 
cells. Lane 2 contained 5 J.Lg of poly (A) + RNA fi:om keratinocytes. 
No signal was visible in this sample . Lanes 3 and 4 contained 
SaOS-2 and mouse kidney total RNA, respectively. As can be seen, 
a highly expressed 2.5 kb PTH/ PTHrP receptor mRNA was found 
in both SaOS-2 and mouse kidney cells . Also visib le in both 
samples was a less prominent transcl;pt at 2.3 kb. Interestingly, 
three smaller transcripts were expressed i11 the SaOS-2 bone cells . 
La11e 5 contained 5 J.Lg of poly (A) + RNA isolated from fibrobla sts . 
The major 2. 5-kb transcript was cleady expressed as well as another 
at 2.3 kb . No smaller transcripts w ere observed even after pro-
longed exposure of the autoradiograph . Ethidium bromide staining 
of the gel and rehybridization of the membrane with an oligonu-
cleotide specific for human GAJ>DH confirmed sampl e integrity 
and relative loading concentrations. In Fig 1A, the GAPDH signals 
were visible in all of the lanes except for lane 4, tl1e mouse kidney 
cells. Because the GAPDH oligonucleotide probe ·was specific for 
hum an cells, no detectable signal was expected. Apparent and 
exp~cted w ere the int~nsities of the GAPDH sig11als in the poly 
(A) RNA fi·om keratmocytes and fibroblasts as compared to the 
GAPDH sig11als from SaOS-2 total RNA. In a comparison hybrid-
ization experiment, five times the amount of poly (A) + RNA from 
keratinocytes as from fibroblasts still did not show PTH/PTHrP-R 
expression , even with prolonged exposure of the autoradiograph 
(data not shown). In a total of five separate analyses the PTH/ 
PTHrP receptor m essages were consistently found in poly (A) + 
RNA samples prepared from cultured dermal fibroblas ts but not 
from cultured keratinocytes . 
RTINESTED PCR Analysis R everse transcriptase and nested 
PCR was used to analyze total RNA isolated from human kerati-
nocytes and fibroblasts as well as from mouse immortalized fibro-
blasts (3T3s) and from human osteosarcoma cells (SaOS-2). In 
these experiments, the success of th e eDNA synthesis from the RT 
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Figure 1. PTH/PTHrP-R expression in cultured human fibro-
blasts as shown by Northern analysis and RT/nested PCR analysis. 
A) Northern blot analysis of total RNA prepared from SaOS-2 (la ues 1 ami 
J) and mouse kidney cells (lau e 4) and poly (A) + RNA from kcratinocytes 
(lau e 2) and fibroblasts (laue 5). The blots were hybridized with the 
full-l ength eDNA encoding the human PTH/ PTHrP receptor. B) Laue 1 
was RT and GAPDH PCR amplification of to tal RNA from human 
keratinocytes cultured without a 3T3 feeder layer. L aue 2 was an aliquot of 
these same cells after RT and nested PCR amplification with PTH/ 
PTHrP-R primers. Laues 3 through 6 arc RT/ nested PCR samples from 
human keratinocytes cttltured with 3T3 cells, human fibroblasts. human 
osteoSilrcoma cell s, a11d 3T3 cell s, respectively. Lane 7 is the nested PCR 
product from the human PTH / PTHrP receptor eDNA . 
reaction was verified by amplifying an aliquot of the R T product 
w ith pdmers for the GAPDH constitutive gen e and confirming by 
gel electrophoresis the presence of the predicted PC R product. For 
PTH/ PTHrP analyses, parallel first-amplification reactions were 
performed on eDNA aliquots and PCR products were analyzed by 
gel electrophoresis. T he first amplification of a human PT H / 
PTHrP receptor eDNA produced the predicted 675-bp product and 
the second amplification produced the predicted 360-bp product. 
Nested PCR analyses of RT products from human keratinocytes 
that w ere initially cultured on a 3T3 feeder layer, as well as from 
human fibroblasts , mou se 3T3 fibrobl asts , and human osteosar-
coma celJs demonstrated identical results to th ose from cl1c human 
PTH/ PTHrP receptor eDN A . In contrast, nested PC R ana.l yses of 
RT products from human keratinocytes that were cultured entirely 
without a 3T3 feeder layer (Fig lB) demonstra ted neither a first 
nor second PCR amplifi cation product. Lan e 1 con tained the 
R T/GAPDH-amplified PCR. product from keratinocytes grown 
~i~hout a 3T3 feeder layer. T he p1·edicted 762-bp product is clearly 
VISible. Lm1e 2 contained an identical aliquot from this R T reaction 
tha.t was amplified via the n es ted PCR protocol previously de-
scnbed. No PCR products were visible. Lane 3 contain ed an 
RT / nested PCR sm11ple from keratinocytes that were cultured w ith 
a 3T3 feeder layer. Lanes 4 tlu·ough 6 were R.T/nested PCR 
samples fl·om human fibroblasts, human osteosarcoma cells , m1d 
mouse 3T3 fibroblasts, respectively. Lane 7 contain ed th e nested 
PCR product from the humm1 PTH/ PTHrP receptor eDNA. As 
can be seen, lanes 3 through 7 displayed identical second-amplifi-
cation PCR products of the predicted 360 bp size. Firs t-am plifica-
tion PCR products of 675 bp were also identical for these samples 
and parallel amplifications with GAPDH primers produced th e 
predicted product (data not shown). R estriction enzyme digests of 
the amplification products with Fok I, Bsg I, and Drd I further 
confirmed their authenticiry. 
DISCUSSION 
Aliliough we [12,13] have demonstrated that specific PTH and 
PT HrP N-terminal fragments arc antiproliferative agents in cu l-
tured human keratinocytes and in mouse epidermis i11 v ir10, North-
ern analyses indicated the PTH/ PTHrP receptor mRNA was not 
expressed in cu ltured keratinocytcs. Jn contrast, cultured dermal 
fibroblasts expressed two PTI-I / PTHrP receptor transcdpts with 
one major band at 2.5 kb and one minor band at 2.3 kb. T he 
transcripts observed in fibroblasts w ere consistent with those seen 
m hybridizations of RNA isolated fi·om SaOS-2 cells and mouse 
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kidney cell s, w hich are known to be PTH/PTHrP receptor positive 
[8] . The presence of two transcripts m ay be due to alternative 
transcrip tion start sites, spl icing, or the presence of closely related 
ml"t.NAs. To in crease detectio n sensitivity for the PTH/PTHrP 
transct"ipt, we uti lized RT/nested PCR. T he resu lts confi rmed the 
Northern ana lyses data and clearly showed that the PTH/PTHrP 
receptor m essage was present in hum an fibro blasts, human osteo-
sarcoma cells and mouse 3T3 cells. In terestingly, the enhanced 
sensitivity of R.T / nested PCR revealed the PTH/PTHrP recepto r 
in kera tinocytes cul tured on a 3T3 feeder layer. Because we found 
the PTH/PTHrP receptor in 3T3 cells, it was thought that RT I 
PCR amp Lification of RNA isolated fi:om keratinocytes grown on a 
3T3 feeder layer co uld generate receptor-positive amplifi ca tion 
products . RT/nested PCR analyses of keratinocytes that were 
cultured witho ut a 3T3 feeder layer demonstrated no PTH/PTJ-IrP 
receptor, suggesting th at the product observed was derived fi·om 
the 3T3 cells of the feeder layer and not from the keratinocytes. 
The data are consistent w ith the additional observatio n that in tra-
cellul ar cAMP levels increased when fibrobla sts were treated with 
PTJ-1 (l-3 4) (10 - 7 M), but in identically treated kera tinocytes there 
was no detectable cAMP response. 
Because the re is no detectab le PTJ-1/PTJ-IrP receptor in human 
cul tured ke ratinocytes, the data raise the possibility that PTHs and 
PTHrPs antipro liferative effects on kera tinocytes ma y be mediated 
by PTJ-1/PTHrP receptors located in adjacent fibroblasts. Such a 
pathway is believed to be one way PTH increases osteoclastic bone 
resorpt ion. Because mature osteoclasts do not have PTH receptors, 
PTH m ay first act on osteoblasts and/ or stromal fibroblasts to 
in crease bone resorption [23]. M oreover, paracrine- and/or auto-
ct"ine-mediated effects on skin cell s by PTHrP are also possible . 
It is also possible that there are differen t receptors for PTH/ 
PTHrP in keratinocytes and fibroblasts. T his idea is strengthened 
fro m the va riability in the biologic potency of difterent PTH/ 
PTHrP analogs in numerous tissues [3] . Studies of the biologic 
effects of several PTJ-I rP fragm ents in different cell types have 
suggested that the re m ay be a PTHrP receptor distinct from the 
classic PTH/PTHrP receptor, which is coupled to adenylate cyclase 
through th e G-protein (7] . For example, recombinant PTHrP 
(1.-141) and PTHrP (1-108) were two to four times more potent 
than PTHrP (1-34) in the stimulatio n of plasminogen activator 
activity in UMR cell s [24]. Simihrly, hPTHrP (1-34) and bPTHrP 
(1-108) were not active in inhibiting bone resorption, w hereas th e 
carboxy-terminal fragment hPTHrP (107-139) was a potent inhib-
itor of bone resorption (25]. Such data suggest that a distinct PTHrP 
receptor(s) m ay recogni ze specific fragments. 
Similarly, other studi es suggest that particular PTHrP fragments 
may induce different signal-transduction mechanisms. Specifica lly, 
O rloff et a/ [26] using sq uam ous carcinoma cells demonstrated that 
hPTHrP (67-86)NH2 or hPTHrP (1-141) ca used a rapid and 
trans ient rise in intracel!uJar ca lcium in a dose-dependent manner 
between 10- 11 M and 1 o-s M but there was no stimulation of 
cAMP formation detectable even with 10 - 6 M hPTHrP (67- 86). In 
a separate study, O rloff eta/ [27] suggest hu man ca rcinoma cells and 
normal keratinocytes express mR.NAs re lated to but distin ct from 
the human PTH receptor mRNA. If there are distinct receptors and 
presumably specific PTH and PTHrP fragment activation sites o n 
these receptors, then this could explain no cAMP formation by 
PTH (1-34) and no PTH/PTHrP receptor expression in keratino-
cytes. 
T hroug h cAMP determinations, North ern anal yses, and RT I 
nested PCR analyses, this study localizes the human PTH/PTHrP 
receptor in fibrob lasts but not in keratinocytes. Numero us ques-
tions remain , however, as to wheth er the bio logic activities ofPTH 
and PTI-IrP in skin cells are m ediated through paracrine and/or 
autocrine pathways o r w hether identical m· distinct receptors exist. 
More resea rch is necessary to understand the biologic activation o f 
endogeno usly occurring PT H and PTHrP in skin cells and the 
potentia l the rape utic use for these hormo nes in regulatin g skin cell 
growth and dilferenti:1tion. 
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